Menu

10x Genomics, Inc. TXG

Full chart Compare
Set alert

Price alert · TXG

All alert types
58.52 USD +0.45 (+0.78%)

Nov 6, 2026, 1:27 PM EST

55.50 Day range 61.99
13.58 52-week range 102.81
YTD
+258.77%
1 year
+350.12%

Revenue & Expenses

Other Income → Expenses: $70.98MExpenses → Selling, General & Admin: $316.13MExpenses → Research & Development: $238.63MExpenses → Income Tax: $3.64MGross Profit → Expenses: $443.88MRevenue → Gross Profit: $443.88MRevenue → Cost of Revenue: $198.94MNet Loss → Expenses: $43.54MOther Income$70.98MGross Profit$443.88MNet Loss$43.54MCost of Revenue$198.94MExpenses$558.40MSelling, General & Admin$316.13MResearch & Development$238.63MIncome Tax$3.64MRevenue$642.82M

Latest period ending Dec 31, 2025 · select a line to chart its full history

TXG annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
642.82M610.78M618.73M516.41M490.49M
443.88M414.48M409.31M396.02M416.40M
-60.98M-194.56M-265.33M-167.94M-52.25M
-43.54M-182.63M-255.10M-166.00M-58.22M
-0.35-1.52-2.18-1.46-0.53
TXG annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
473.97M344.07M359.28M227.35M596.07M
1.04B918.64M965.14M1.03B1.02B
245.04M208.50M224.10M223.24M201.26M
84.36M82.61M95.37M95.18M81.98M
796.33M710.13M741.04M805.74M817.57M
TXG annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
136.05M6.66M-15.20M-33.61M-21.37M
-13.44M-32.63M133.49M-350.89M-106.73M
6.80M10.91M13.67M15.82M35.30M
-5.93M-12.39M-48.60M-131.66M-101.28M
129.90M-15.22M131.93M-368.72M-92.57M